740 related articles for article (PubMed ID: 16461184)
21. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
Gosse P; Roudaut R; Herrero G; Dallocchio M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
[TBL] [Abstract][Full Text] [Related]
22. Aldosterone excess and resistance to 24-h blood pressure control.
Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
[TBL] [Abstract][Full Text] [Related]
23. Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy.
Hashimoto J; Watabe D; Hatanaka R; Hanasawa T; Metoki H; Asayama K; Ohkubo T; Totsune K; Imai Y
Am J Hypertens; 2006 Jan; 19(1):27-32. PubMed ID: 16461187
[TBL] [Abstract][Full Text] [Related]
24. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
25. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
[TBL] [Abstract][Full Text] [Related]
26. Morning blood pressure hyper-reactivity is an independent predictor for hypertensive cardiac hypertrophy in a community-dwelling population.
Kaneda R; Kario K; Hoshide S; Umeda Y; Hoshide Y; Shimada K
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1528-33. PubMed ID: 16364820
[TBL] [Abstract][Full Text] [Related]
27. Role of plasma aldosterone concentration in regression of left-ventricular mass following antihypertensive medication.
Yoshida C; Goda A; Naito Y; Nakaboh A; Matsumoto M; Otsuka M; Ohyanagi M; Hirotani S; Lee-Kawabata M; Tsujino T; Masuyama T
J Hypertens; 2011 Feb; 29(2):357-63. PubMed ID: 21052021
[TBL] [Abstract][Full Text] [Related]
28. Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma.
Denolle T; Chatellier G; Julien J; Battaglia C; Luo P; Plouin PF
Am J Hypertens; 1993 Nov; 6(11 Pt 1):907-13. PubMed ID: 8305163
[TBL] [Abstract][Full Text] [Related]
29. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
Brilla CG; Matsubara LS; Weber KT
J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
[TBL] [Abstract][Full Text] [Related]
30. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
[TBL] [Abstract][Full Text] [Related]
31. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
Brilla CG; Rupp H; Maisch B
Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
[TBL] [Abstract][Full Text] [Related]
32. Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function--a pilot study.
Gosse P; Gressin V; Clerson P; Lemetayer P; Clémenty J
Therapie; 1999; 54(2):217-22. PubMed ID: 10394257
[TBL] [Abstract][Full Text] [Related]
33. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
34. Association between the morning-evening difference in home blood pressure and cardiac damage in untreated hypertensive patients.
Matsui Y; Eguchi K; Shibasaki S; Shimizu M; Ishikawa J; Shimada K; Kario K
J Hypertens; 2009 Apr; 27(4):712-20. PubMed ID: 19516171
[TBL] [Abstract][Full Text] [Related]
35. Ventricular arrhythmias and left ventricular hypertrophy in essential hypertension.
Palmiero P; Maiello M
Minerva Cardioangiol; 2000 Dec; 48(12):427-34. PubMed ID: 11253327
[TBL] [Abstract][Full Text] [Related]
36. Diastolic dysfunction is associated with insulin resistance, but not with aldosterone level in normotensive offspring of hypertensive families.
Zizek B; Poredos P; Trojar A; Zeljko T
Cardiology; 2008; 111(1):8-15. PubMed ID: 18239385
[TBL] [Abstract][Full Text] [Related]
37. Control of hypertension in treated children and its association with target organ damage.
Seeman T; Dostálek L; Gilík J
Am J Hypertens; 2012 Mar; 25(3):389-95. PubMed ID: 22089110
[TBL] [Abstract][Full Text] [Related]
38. Relationship between insulin resistance and end-organ damage in white coat hypertension.
Tunçkale A; Aran SN; Karpuz H; Dirican A
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1011-6. PubMed ID: 15533726
[TBL] [Abstract][Full Text] [Related]
39. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.
Chang YY; Liao CW; Tsai CH; Chen CW; Pan CT; Chen ZW; Chen YL; Lin LC; Chang YR; Wu VC; Wu KD; Hung CS; Lin YH; ;
J Am Heart Assoc; 2019 Nov; 8(22):e013263. PubMed ID: 31718437
[TBL] [Abstract][Full Text] [Related]
40. Association between hypervolemia and ventricular hypertrophy in hemodialysis patients.
Martin LC; Franco RJ; Gavras I; Matsubara BB; Garcia S; Caramori JT; Barretti BB; Balbi AL; Barsanti R; Padovani C; Gavras H
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1163-9. PubMed ID: 15607624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
